Kaupinen Wes - 13 Dec 2024 Form 3/A - Amendment Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
13 Dec 2024
Net transactions value
$0
Form type
3/A - Amendment
Filing time
06 Jan 2025, 16:59:17 UTC
Date Of Original Report
16 Dec 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PVLA Common Stock 44,410 13 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1,470 shares of common stock were inadvertently omitted from the reporting person's original Form 3.